Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FOSTER-C pilot trial of fosamprenavir activity against genotype 1 hepatitis C in HIV/HCV coinfected patients
2010-023503-10Phase 4Completed
- Sponsor
- Fundación SEIMC-GeSIDA
- Start
- Nov 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of fosamprenavir and ritonavir in Hepatitis C genotype 1 and human immunodeficiency virus infection (HIV) (2 arms), sponsored by Fundación SEIMC-GeSIDA. Started Nov 2010; status: completed.
02
Drugs
fosamprenavirritonavir
03
Conditions
Hepatitis C genotype 1human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on 2010-023503-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-023503-10.